Brain+ ApS
Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla " your CST Assistant, a software-based dementia … Read more
Brain+ ApS (BRAINP) - Total Assets
Latest total assets as of June 2025: Dkr35.35 Million DKK
Based on the latest financial reports, Brain+ ApS (BRAINP) holds total assets worth Dkr35.35 Million DKK as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Brain+ ApS - Total Assets Trend (2015–2024)
This chart illustrates how Brain+ ApS’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Brain+ ApS - Asset Composition Analysis
Current Asset Composition (December 2024)
Brain+ ApS's total assets of Dkr35.35 Million consist of 2.5% current assets and 97.5% non-current assets.
| Asset Category | Amount (DKK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 0.2% |
| Accounts Receivable | Dkr707.52K | 2.1% |
| Inventory | Dkr0.00 | 0.0% |
| Property, Plant & Equipment | Dkr0.00 | 0.0% |
| Intangible Assets | Dkr32.22 Million | 97.2% |
| Goodwill | Dkr0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how Brain+ ApS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Brain+ ApS's current assets represent 2.5% of total assets in 2024, a decrease from 21.0% in 2015.
- Cash Position: Cash and equivalents constituted 0.2% of total assets in 2024, down from 4.8% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 97.0% of total assets, an increase from 78.0% in 2015.
- Asset Diversification: The largest asset category is intangible assets at 97.2% of total assets.
Brain+ ApS Competitors by Total Assets
Key competitors of Brain+ ApS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM48.46 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥265.74 Million |
|
BIT Computer Co. Ltd
KQ:032850
|
Korea | ₩82.38 Billion |
|
ezCaretech Co. LTD
KQ:099750
|
Korea | ₩56.71 Billion |
|
SyntekaBio Inc
KQ:226330
|
Korea | ₩33.49 Billion |
|
Carelabs Co.Ltd
KQ:263700
|
Korea | ₩105.15 Billion |
|
Shanghai Kingstar Winning Software
SHE:300253
|
China | CN¥8.35 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
Brain+ ApS - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Brain+ ApS generates 0.24x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Brain+ ApS is currently not profitable relative to its asset base.
Brain+ ApS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.80 | 1.40 | 0.25 |
| Quick Ratio | 1.80 | 1.40 | 0.25 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Dkr2.26 Million | Dkr 1.79 Million | Dkr -19.24 Million |
Brain+ ApS - Advanced Valuation Insights
This section examines the relationship between Brain+ ApS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.28 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -7.9% |
| Total Assets | Dkr33.13 Million |
| Market Capitalization | $968.01 USD |
Valuation Analysis
Below Book Valuation: The market values Brain+ ApS's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Brain+ ApS's assets decreased by 7.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Brain+ ApS (2015–2024)
The table below shows the annual total assets of Brain+ ApS from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Dkr33.13 Million | -7.88% |
| 2023-12-31 | Dkr35.97 Million | -20.72% |
| 2022-12-31 | Dkr45.37 Million | -3.22% |
| 2021-12-31 | Dkr46.88 Million | +56.86% |
| 2020-12-31 | Dkr29.89 Million | +25.53% |
| 2019-12-31 | Dkr23.81 Million | +4.57% |
| 2018-12-31 | Dkr22.77 Million | +40.14% |
| 2017-12-31 | Dkr16.25 Million | +45.76% |
| 2016-12-31 | Dkr11.15 Million | +22.25% |
| 2015-12-31 | Dkr9.12 Million | -- |